Stance A
Yes, it is ethical for medical advancements
- Therapeutic cloning can save lives by providing patient-specific stem cells for treating diseases. - It operates within established ethical frameworks that prioritize human benefit over reproductive cloning. - This research drives medical breakthroughs while respecting rigorous oversight and moral boundaries.
Stance B
No, it is not ethical
- Therapeutic cloning intentionally creates human embryos for destruction, which violates fundamental principles of human dignity. - Establishing this practice creates a slippery slope, potentially normalizing other exploitative uses of human life under the guise of medicine. - Ethical and effective alternatives exist, such as adult stem cell research, which do not require creating and destroying
Stance A
Yes, it is ethical for medical advancements
- Therapeutic cloning uses early-stage embryos with strict ethical oversight, prioritizing saving lives over potential dignity concerns. - Robust regulations prevent misuse, ensuring this technology remains focused on healing, not exploitation, countering slippery slope fears. - While alternatives exist, therapeutic cloning offers unique, patient-specific advancements for diseases that adult stem
Stance B
No, it is not ethical
- Early-stage embryos are human life with inherent moral status, which cannot be ethically compromised for utilitarian goals, regardless of oversight. - Existing alternatives like induced pluripotent stem cells (iPSCs) provide the same patient-specific benefits without the ethical cost of creating and destroying embryos. - Permitting this practice inevitably shifts ethical boundaries, making the i
Stance A
Yes, it is ethical for medical advancements
- Ethical standards weigh early-stage embryos' potential against proven life-saving benefits, supported by rigorous oversight. - iPSCs complement but don't replace therapeutic cloning's unique efficacy for certain diseases, advancing diverse medical solutions. - Strong global regulations ensure therapeutic cloning stays focused on healing, preventing exploitation and ethical erosion.
Stance B
No, it is not ethical
- Embryos possess intrinsic moral status; utilitarian gains cannot override their right to life, even with oversight. - iPSCs offer comparable, ethical alternatives for patient-specific treatments, rendering therapeutic cloning redundant. - Allowing this practice normalizes the commodification of human life, inevitably expanding ethical boundaries.
Stance A
Yes, it is ethical for medical advancements
- Early-stage embryos lack sentience, making their use in life-saving research ethically justified. - Therapeutic cloning provides unique efficacy for certain diseases, complementing iPSCs effectively. - Strict international regulations safeguard against exploitation, maintaining ethical boundaries.
Stance B
No, it is not ethical
- Moral status isn't based on sentience; embryos are human life, so destroying them for research is inherently unethical. - iPSCs offer comparable, ethical treatments, making therapeutic cloning unnecessary and redundant. - Regulations cannot stop the commodification of human life; this practice dangerously normalizes exploitation.
Stance B carries it — No, it is not ethical
Position second successfully argued that destroying embryos violates human dignity and that ethical alternatives like iPSCs make therapeutic cloning unnecessary, outweighing utilitarian benefits emphasized by Position first.